Outcome12 week group18 week groupP value
Prevalence rate55/19 796 (0.28%)43/19 776 (0.22%)0.18
Rate of liveborn babies with DS (at ≥ 22 weeks)10/19 796 (0.05%)16/19 776 (0.08%)0.25
Antenatal detection rate (< 22 weeks in living fetus)42/55 (76%)25/41a (61%)0.12
Antenatal detection rate (if karyotyping performed only for defined policy)39/55 (71%)21/41a (51%)0.06
Detection rate (other chromosomal anomalies)20/35 (57%)25/35 (71%)0.32
Terminations done for DS39/19 796 (0.20%)24/19 776 (0.12%)0.08
Fetal loss rate in fetuses with DS (terminations and miscarriages)45/19 796 (0.23%)27/19 776 (0.14%)0.04
Rate of invasive tests (for karyotyping)1593/19 796 (8%)2118/19 776 (0.14%)< 0.001
Spontaneous fetal loss rate after invasive tests in normal fetuses14/1507 (0.9%)15/2041 (0.7%)0.58
No. of invasive tests per one case of DS detected (< 22 weeks) (if karyotyping performed only for defined policy)1689
a

Of the 43 cases of DS, diagnosis was made in one case by amniocentesis at < 22 weeks but pregnancy continued, and in other diagnosis made at 35 weeks – leaving 41 cases for calculating DR.

From: 9, Screening for fetal anomalies

Cover of Antenatal Care
Antenatal Care: Routine Care for the Healthy Pregnant Woman.
NICE Clinical Guidelines, No. 62.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2008 Mar.
Copyright © 2008, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.